888-254-6267
Contact Us
Request a Demo

Contact Us

Request a Demo

Clincosm
Demo Sign In

Condition

Overall Status

Phase

Sponsor New

Sign Up

Intervention New

Study Results

Study Documents

Intervention Type

Funder Type

Study Type

Age Group

Gender

City

Lymphoma, Non Hodgkin Clinical Trials

Create an account to Download
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Recruiting
  • Lymphocytic Leukemia, Chronic
  • Lymphoma, Non Hodgkin
  • BTCT4465A (Mosunetuzumab) IV
  • +2 more
  • Duarte, California
  • +55 more
2022-03-17
Mar 17, 2022
G
A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma - 2018
Completed
Has Results
  • Lymphoma, Non Hodgkin
  • Cyclophosphamide
  • +6 more
  • Birmingham, Alabama
  • +10 more
2020-02-18
Feb 18, 2020
H
MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma - 2017
Completed
Has Results
  • Lymphoma, Non Hodgkin
  • Rituximab
  • Vitoria, Alava, Spain
  • +38 more
2018-12-04
Dec 4, 2018
G
An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma - 2014
Completed
  • Lymphoma, Non Hodgkin
    • (no location specified)
    2017-03-21
    Mar 21, 2017

    Do More

    • Create up to 2 groups of studies for comparison and sharing
    • Get notified when studies are updated
    • Download tabulated search results instantly
    • Unlimited searches
    Sign UpNot Today
    Clincosm Logo white
    2022 © Clincosm, Inc.
    Exploring the universe of clinical trials just got cosmically easier.
    About
    Blog
    Terms
    Privacy Policy
    Newest Clinical Trials